We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+294.99%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$72.5M
AUM Growth
+$48.6M
Cap. Flow
+$28.8M
Cap. Flow %
39.79%
Top 10 Hldgs %
98.3%
Holding
24
New
4
Increased
12
Reduced
1
Closed
6

Top Buys

1
AGRX
Agile Therapeutics
AGRX
+$9.06M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1M
3
CSW
CSW Industrials
CSW
+$350K
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$250K
5
DOV icon
Dover
DOV
+$197K

Top Sells

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$688K
2
NSL
NUVEEN SENIOR INCM FD
NSL
+$418K
3
PHD
Pioneer Floating Rate Fund
PHD
+$321K
4
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$287K
5
JRO
Nuveen Floating Rate Income Opportunty Fund
JRO
+$258K

Sector Composition

1 Healthcare 8.11%
2 Financials 2.69%
3 Industrials 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$27.8M 38.34%
135,186
+97,935
+263% +$19.1M
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$25.6M 35.36%
2,322,769
+76,300
+3% +$250K
AGRX
3
DELISTED
Agile Therapeutics
AGRX
$8.87M 12.24%
714
+702
+5,850% +$9.06M
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$12.8B
$5.21M 7.19%
620,138
+227
+0% +$1.9K
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.29M 1.78%
9,116
+7,570
+490% +$1M
ACAS
6
DELISTED
American Capital Ltd
ACAS
$1.04M 1.44%
68,537
-84
-0.1% -$1.17K
IWM icon
7
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$591K 0.82%
+5,338
New +$553K
CSW
8
CSW Industrials
CSW
$4.56B
$344K 0.47%
+10,906
New +$350K
SCM icon
9
Stellus Capital Investment Corp
SCM
$220M
$240K 0.33%
23,489
+2,109
+10% +$19.1K
ICMB icon
10
Investcorp Credit Management BDC
ICMB
$12.3M
$237K 0.33%
28,418
+13,293
+88% +$111K
KPTI icon
11
Karyopharm Therapeutics
KPTI
$216M
$221K 0.31%
+1,655
New +$183K
DOV icon
12
Dover
DOV
$28.8B
$211K 0.29%
+4,067
New +$197K
PFX icon
13
PhenixFIN
PFX
$88.7M
$179K 0.25%
1,355
+520
+62% +$66.5K
ABUS icon
14
Arbutus Biopharma
ABUS
$901M
$173K 0.24%
41,903
+12,141
+41% +$43.4K
CDTX
15
DELISTED
Cidara Therapeutics
CDTX
$163K 0.22%
641
– –
ACSF
16
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$155K 0.21%
15,457
+2,300
+17% +$20.5K
ASMB icon
17
Assembly Biosciences
ASMB
$531M
$111K 0.15%
1,849
+341
+23% +$22.8K
MDGL icon
18
CALL
Madrigal Pharmaceuticals
MDGL
$12.8B
$16K 0.02%
1,914
+143
+8% +$1.19K
FRA icon
19
BlackRock Floating Rate Income Strategies Fund
FRA
$380M
– –
-22,285
Closed -$287K
PHD
20
DELISTED
Pioneer Floating Rate Fund
PHD
– –
-29,603
Closed -$321K
NSL
21
DELISTED
NUVEEN SENIOR INCM FD
NSL
– –
-72,363
Closed -$418K
SRRA
22
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-1,143
Closed -$688K
MDLY
23
DELISTED
Medley Management Inc
MDLY
– –
-3,289
Closed -$187K
JRO
24
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
– –
-26,314
Closed -$258K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q1 2016 Portfolio in Review

As of Q1 2016, Caxton Corporation held 24 positions worth $72.5M, up 204% from $23.8M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Caxton Corporation deployed $28.8M of net new capital in Q1 2016, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was CSW Industrials: 10,906 shares worth $344K.

By sector, the portfolio is most concentrated in Healthcare at 8.1% of assets, down from 37% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was American Capital Ltd, an estimated $1.17K trimmed.

  • Caxton Corporation's largest Q1 2016 buy was CSW Industrials: 10,906 shares worth $344K.
  • Caxton Corporation added most to Agile Therapeutics in Q1 2016, an estimated $9.06M increase.
  • Caxton Corporation's biggest Q1 2016 reduction was American Capital Ltd, cutting an estimated $1.17K.
  • Caxton Corporation fully exited Sierra Oncology, Inc. Common Stock in Q1 2016, selling an estimated $688K.
  • Caxton Corporation's ten largest holdings make up 98% of its $72.5M portfolio in Q1 2016.
  • Caxton Corporation opened 4 new positions and closed 6 in Q1 2016.
  • Caxton Corporation's portfolio value rose 204% quarter-over-quarter to $72.5M.

Based on Caxton Corporation's 13F filing for Q1 2016, filed 16 May 2016.